Sofía
Calleja Aznarez
Investigadora hasta 2024
Publicaciones (9) Publicaciones de Sofía Calleja Aznarez
2024
-
Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine
Pharmaceuticals, Vol. 17, Núm. 1
2023
-
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety
Pharmaceutics, Vol. 15, Núm. 2
-
Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
Frontiers in Pharmacology, Vol. 14
2022
-
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam
Biomedicine and Pharmacotherapy, Vol. 155
-
Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes
Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 7, pp. 1003-1010
-
Modification of baseline status to improve breath tests performance
Scientific Reports, Vol. 12, Núm. 1
-
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline
Pharmaceutics, Vol. 14, Núm. 10
2020
-
Estudio del test de tolerancia a lactosa como alternativa a test de hidrógeno espirado en el estudio de la malabsorción de lactosa
Advances in Laboratory Medicine, Vol. 1, Núm. 4
-
Lactose tolerance test as an alternative to hydrogen breath test in the study of lactose malabsorption
Advances in Laboratory Medicine, Vol. 1, Núm. 4